Patent · US Active

Therapeutic compounds

US8765812B2 · kind B2 · utility

5Cited by

15References

10Claims

0Family size

Assignee

Fibrotech Therapeutics PTY LTD · AU

Inventors

Spencer John Willams · Sydney, AU
David Stapleton · Melbourne, AU
Steven Zammit · Melbourne, AU
Darren James Kelly · Smiths Gully, AU
Richard Ernest Gilbert · Toronto, CA
Henry Krum · Melbourne, AU

Key dates

Filing date	Jul 5, 2007
Grant date	Jul 1, 2014
Priority date	—
Expiry date	Sep 20, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2603/74
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Substituted cinnamoyl anthranilate compounds exhibiting anti-fibrotic activity; or derivatives thereof, analogues thereof, pharmaceutically acceptable salts thereof, and metabolites thereof; with the proviso that the compound is not Tranilast.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.